| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |